iAmHealthy Clinical Practice Guideline (CPG)
Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Mar 19, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Obesity poses a major health risk, contributing to elevated morbidity and mortality from cancer, cardiovascular disease, and diabetes. Children living in rural areas have higher rates of obesity than their urban counterparts. Based upon our extensive prior work, the investigators propose a multilevel factorial design randomized controlled trial with interventions at the clinic and individual patient level to treat pediatric obesity among underserved rural children and families. The individual intervention is an mHealth rurally tailored pediatric obesity behavioral intervention (iAmHealthy) ...
Gender
ALL
Eligibility criteria
- Inclusion criteria for individual participants:
- • Child is ages 6-11 years at consent
- • Child BMI %ile is ≥85th
- • Child lives in a rural area
- • Child/family speaks English or Spanish
- Exclusion criteria for individual participants:
- • Child has a physical limitation or injury that substantially limits physical mobility or has a planned medical treatment during the course of the trial that will substantially limit physical mobility
- • Child has a known medical issue that could affect protocol compliance (e.g., cancer)
- • Child and/or primary caregiver has a developmental delay or cognitive impairment that could affect protocol compliance
- • Child is enrolled in a weight-loss trial
- • Child has a sibling who has already consented in the trial
- Inclusion criteria for clinics:
- • History of collaboration with site awardee in research or quality improvement projects
- • In the past year at least 300 eligible potential participants
- • The clinic must have an electronic medical records system
- Exclusion criteria for clinics:
- • Unable to generate lists of children seen in clinic by date of visit, age, and zip code
Trial Officials
Ann Davis, PhD, MPH, ABPP
Principal Investigator
University of Kansas Medical Center
Paul M Darden, MD
Principal Investigator
The University Of Oklahoma Health Sciences Center
About University Of Kansas Medical Center
The University of Kansas Medical Center (KUMC) is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent clinical trial sponsor, KUMC leverages its extensive expertise in diverse medical fields to conduct rigorous clinical research aimed at improving patient outcomes and developing new treatment modalities. With a commitment to ethical standards and patient safety, KUMC collaborates with multidisciplinary teams to facilitate groundbreaking studies that address significant health challenges, ultimately contributing to the advancement of medical knowledge and the enhancement of community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Kansas, United States
Charleston, South Carolina, United States
Oklahoma City, Oklahoma, United States
Omaha, Nebraska, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported